Telomir Pharmaceuticals (TELO) has recently gained significant attention following a local ABC exclusive that showcased impressive results from their novel "age reversal" pill in two senior dogs. This compassionate use study has sparked interest in Telomir's stock.

This article What if you could ‘grow younger’? Meet the new pill that’s redefining what’s possible for aging bodies, starting with our furry friends! 🧬 appeared first on Guerilla Stock Trading.

Alnylam Pharmaceuticals recently presented comprehensive results from a clinical trial for its drug, vutrisiran, aimed at treating transthyretin…

This article 28% lower risk of death, 33% risk reduction—Could this be the new standard of care for a deadly heart condition? 🤔 appeared first on Guerilla Stock Trading.

The Matrix hums with energy, a digital world where the line between reality and illusion blurs. Within this…

This article The Matrix is whispering again… Investors, are you ready to listen? The next big thing is here, and it’s ancient 🦠 appeared first on Guerilla Stock Trading.

MIRA Pharmaceuticals’ stock soared by 318% on Monday, July 22, 2024, following the announcement of positive pre-clinical trial…

This article MIRA Pharmaceuticals skyrockets 318% after breakthrough pre-clinical trial results! 🧠 appeared first on Guerilla Stock Trading.

Nutriband (NTRB) has seen a notable rise in its stock price due to several key factors. The company…

This article Nutriband just saw an 11.18% surge in a single day! With a decline in short interest and positive moving averages, is this your next big buy? 💸 appeared first on Guerilla Stock Trading.

Phathom Pharmaceuticals (PHAT) stock has been trending upwards for various reasons. As of July 11, 2024, the stock…

This article Analysts predict a 73.64% upside for PHAT! Are you ready to ride the wave? 📊 appeared first on Guerilla Stock Trading.

Sarepta Therapeutics’ stock is rising due to its inclusion in the S&P MidCap 400, expanded FDA approval for…

This article FDA Approval Game-Changer: Sarepta’s Elevidys gene therapy just got a green light—huge impact on the stock! ✅ appeared first on Guerilla Stock Trading.

On May 18, 2024, Mirum Pharmaceuticals revealed important findings at the 56th ESPGHAN Annual Meeting in Milan, showcasing…

This article Mirum Pharmaceuticals’ latest findings: Game-changing liver treatment delivers lasting relief appeared first on Guerilla Stock Trading.

Amphastar Pharmaceuticals is experiencing a bullish trend reversal following their strong Q1 2024 financial performance. The company reported…

This article Amphastar’s product portfolio is thriving – discover how this pharma giant is conquering new markets! appeared first on Guerilla Stock Trading.

In the realm of pharmaceuticals, innovation often leads the way to groundbreaking treatments and advancements in healthcare. Recently,…

This article Revolutionizing Cardiovascular Treatment: Novo Nordisk’s Strategic Expansion appeared first on Guerilla Stock Trading.